MedPath

The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis

Conditions
Lung Disease
Lung Neoplasm
Registration Number
NCT02965300
Lead Sponsor
Chinese PLA General Hospital
Brief Summary

The purpose of this study is to analysis the volatile organic gases(VOCs) in exhaled breath of pulmonary lesion patients and healthy controls, in order to find the difference of composition and concentration among groups.

Detailed Description

Collect the exhaled gas in pulmonary lesion patients and healthy controls, using proton transfer reaction mass spectrometry to analysis the different composition and concentration of VOCs, to find the biomarker gases of distinguishing benign and malignant lesion of lung among different groups, and try to build a diagnostic model for lung lesion.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
230
Inclusion Criteria
  • cohort 1 :

Inclusion criteria:

Patients newly diagnosed with primary lung cancer by tissue biopsy and did not receive any treatment aiming at the tumor, including chemotherapy and radiotherapy.

Age ≥ 18 years

  • cohort 2: Inclusion criteria: Patients diagnosed with pulmonary benign lesion by tissue biopsy or other examination.

Age ≥ 18 years

Exclusion Criteria

patients who have more than one type of carcinoma patients diagnosed type 2 diabetes mellitus patients diagnosed chronic renal failure patients diagnosed upper digestive tract ulcer patients who reject to sign the informed consent from

  • cohort 3: Healthy controls Volunteers without diagnosed lung diseases and pulmonary symptoms.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mass-to-charge Ratio6 months

It is the measurement result of VOCs in exhaled breath using PTR-MS device.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

department of respiratory department ,Chinese PLA general hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath